Lingotto Investment Management’s Moderna MRNA Stock Holding History

Lingotto Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$53.5M	Hold	763,907	–	–	1.15%	18
2026 Q1	$38.8M	Buy	763,907 +265,214	+53%	+$12.4M	0.77%	20
2025 Q4	$14.7M	Buy	498,693 +125,598	+34%	+$3.41M	0.26%	27
2025 Q3	$9.64M	Hold	373,095	–	–	0.18%	27
2025 Q2	$10.3M	Hold	373,095	–	–	0.22%	27
2025 Q1	$10.6M	Hold	373,095	–	–	0.28%	26
2024 Q4	$15.5M	Hold	373,095	–	–	0.42%	25
2024 Q3	$24.9M	Buy	373,095 +25,000	+7%	+$2.3M	0.72%	20
2024 Q2	$41.3M	Buy	348,095 +45,000	+15%	+$5.69M	1.39%	14
2024 Q1	$32.3M	Buy	303,095 +70,000	+30%	+$7.06M	1.35%	14
2023 Q4	$23.2M	Buy	233,095 +100,000	+75%	+$8.41M	1.12%	15
2023 Q3	$13.7M	Hold	133,095	–	–	0.74%	17
2023 Q2	$16.2M	Buy	+133,095	New	+$17.8M	1.04%	15

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Lingotto Investment Management's MRNA Position: Q2 2026 in Review

Lingotto Investment Management held its Moderna (MRNA) position steady in Q2 2026 at 763,907 shares worth $53.5M. The position accounts for 1.15% of the portfolio, ranked #18.

Lingotto Investment Management first reported a position in MRNA in Q2 2023 and has held it in 13 quarters since. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Lingotto Investment Management held 763,907 shares of Moderna worth $53.5M as of Q2 2026.
Lingotto Investment Management left its Moderna share count unchanged in Q2 2026.
Moderna made up 1.15% of Lingotto Investment Management's portfolio in Q2 2026, its #18 holding.
Lingotto Investment Management first reported a position in Moderna in Q2 2023 and has held it in 13 quarters since.
775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Lingotto Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.